BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7792838)

  • 1. Graft vasculopathy among recipients of heart transplantation during the first 12 years of life. The Pediatric Heart Transplant Group.
    Bailey LL; Zuppan CW; Chinnock RE; Johnston JK; Razzouk AJ; Gundry SR
    Transplant Proc; 1995 Jun; 27(3):1921-5. PubMed ID: 7792838
    [No Abstract]   [Full Text] [Related]  

  • 2. Socioeconomic position and graft failure in pediatric heart transplant recipients.
    Singh TP; Gauvreau K; Bastardi HJ; Blume ED; Mayer JE
    Circ Heart Fail; 2009 May; 2(3):160-5. PubMed ID: 19808335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of graft coronary artery disease in heart-lung transplant recipients.
    Smith JA; Stewart S; Roberts M; McNeil K; Schofield PM; Higenbottam TW; Nashef SA; Large SR; Wells FC; Wallwork J
    Transplant Proc; 1995 Jun; 27(3):2019-20. PubMed ID: 7792872
    [No Abstract]   [Full Text] [Related]  

  • 4. Graft coronary disease in pediatric heart and combined heart-lung transplant recipients: a study of fifteen cases.
    Berry GJ; Rizeq MN; Weiss LM; Billingham ME
    J Heart Lung Transplant; 1993; 12(6 Pt 2):S309-19. PubMed ID: 8312350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplant vasculopathy is associated with increased AlloMap gene expression score.
    Yamani MH; Taylor DO; Rodriguez ER; Cook DJ; Zhou L; Smedira N; Starling RC
    J Heart Lung Transplant; 2007 Apr; 26(4):403-6. PubMed ID: 17403484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dobutamine stress echocardiography for detection of transplant coronary vasculopathy: comparison with angiography and intracoronary ultrasound.
    Spes CH; Mudra H; Schnaack SD; Klauss V; Rieber J; Reichle F; Krüger TM; Uberfuhr P; Angermann CE; Theisen K
    Transplant Proc; 1995 Jun; 27(3):1973-4. PubMed ID: 7792855
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute rejection and cytomegalovirus infection: correlation with cardiac allograft vasculopathy.
    Mangiavacchi M; Frigerio M; Gronda E; Danzi GB; Bonacina E; Masciocco G; Olivia F; De Vita C; Pellegrini A
    Transplant Proc; 1995 Jun; 27(3):1960-2. PubMed ID: 7792851
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-dose cyclosporine treatment fails to prevent coronary luminal narrowing after heart transplantation.
    Vassalli G; Kaski JC; Tousoulis D; Kiowski W; Turina M; Follath F; Gallino A
    J Heart Lung Transplant; 1996 Jun; 15(6):612-9. PubMed ID: 8794036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pravastatin therapy is associated with reduction in coronary allograft vasculopathy in pediatric heart transplantation.
    Mahle WT; Vincent RN; Berg AM; Kanter KR
    J Heart Lung Transplant; 2005 Jan; 24(1):63-6. PubMed ID: 15653381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does donor and recipient sex influence the development of cardiac allograft vasculopathy?
    Mehra MR; Ventura HO; Escobar A; Cassidy CA; Smart FW; Stapleton DD
    Transplant Proc; 1995 Jun; 27(3):1926-9. PubMed ID: 7792839
    [No Abstract]   [Full Text] [Related]  

  • 11. Low HDL-C predicts the onset of transplant vasculopathy in pediatric cardiac recipients on pravastatin therapy.
    Hedman M; Pahlman R; Sundvall J; Ehnholm C; Syvänne M; Jokinen E; Jauhiainen M; Holmberg C; Antikainen M
    Pediatr Transplant; 2007 Aug; 11(5):481-90. PubMed ID: 17631015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrhythmias in pediatric heart transplant recipients: prevalence and association with death, coronary artery disease, and rejection.
    Park JK; Hsu DT; Hordof AJ; Addonizio LJ
    J Heart Lung Transplant; 1993; 12(6 Pt 1):956-64. PubMed ID: 8312320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cause of death in pediatric and infant heart transplant recipients: review of a 20-year, single-institution cohort.
    Zuppan CW; Wells LM; Kerstetter JC; Johnston JK; Bailey LL; Chinnock RE
    J Heart Lung Transplant; 2009 Jun; 28(6):579-84. PubMed ID: 19481018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise capacity improves with time in pediatric heart transplant recipients.
    Dipchand AI; Manlhiot C; Russell JL; Gurofsky R; Kantor PF; McCrindle BW
    J Heart Lung Transplant; 2009 Jun; 28(6):585-90. PubMed ID: 19481019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric cardiac retransplant: differing patterns of primary graft failure by age at first transplant.
    Karamichalis JM; Miyamoto SD; Campbell DN; Smith J; McFann KK; Clark S; Pietra B; Mitchell MB
    J Thorac Cardiovasc Surg; 2011 Jan; 141(1):223-30. PubMed ID: 21047651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental cardiac allograft vasculopathy in mice.
    Ardehali A; Billingsley A; Laks H; Drinkwater DC; Sorensen TJ; Drake TA
    J Heart Lung Transplant; 1993; 12(5):730-5. PubMed ID: 8241210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac re-transplantation in pediatrics: a multi-institutional study.
    Chin C; Naftel D; Pahl E; Shankel T; Clark ML; Gamberg P; Kirklin J; Webber S;
    J Heart Lung Transplant; 2006 Dec; 25(12):1420-4. PubMed ID: 17178335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathology and etiology of chronic rejection of the heart.
    Billingham ME
    Clin Transplant; 1994 Jun; 8(3 Pt 2):289-92. PubMed ID: 8061370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart transplantation at the Heart Center North Rhine-Westfalia.
    Tenderich G; Zittermann A; Schulz U; Schulte-Eistrup S; Schleithoff SS; Wlost S; Körfer R
    Clin Transpl; 2008; ():151-61. PubMed ID: 19708454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.